Biomea Fusion, Inc.
Pharmaceutical company · San Carlos, California, United States · Nasdaq: BMEA
Biomea Fusion, Inc. is a pharmaceutical company headquartered in San Carlos, California, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker BMEA. It has reported private securities offerings to the US SEC, most recently $56 million sold in a notice filed in 2021.
Biomea Fusion at a glance
What does Biomea Fusion do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $56 million sold (2021).
Frequently asked questions about Biomea Fusion
Where is Biomea Fusion headquartered?
Biomea Fusion, Inc. is headquartered in San Carlos, California, United States.
What does Biomea Fusion do?
Biomea Fusion, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Biomea Fusion a public company?
Yes. Biomea Fusion, Inc. trades on Nasdaq under the ticker BMEA.
When was Biomea Fusion founded?
The earliest incorporation on record for Biomea Fusion, Inc. is in 2017, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.